Momenta And Sandoz Pay $120m To Settle Enoxaparin Suit

Result Of Class-Action Suit ‘Extraordinary,’ Court Hears

 
• By Dean Rudge
  
Dollar_Gavel
The settlement was granted preliminary approval at the beginning of the year • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin